Table 1 Demographics and clinical characteristics

No. of participants

51

27

30

Age (mean ± SD)

53.4 ± 11.9

44.8 ± 16.6

54.2 ± 12.3

Sex (% females)

73%

100%

57%

Age of diagnosis of OAB or IC/BPS (mean ± SD)

47.5 ± 15.2

38.8 ± 10.3

NA

% with OAB or IC/BPS symptoms less than one year? (early onset cases)

24%

22%

NA

Comorbidities:

  Hypertension

37%

30%

33%

  Diabetes

8%

0%

3%

  Stroke, TIA

8%

0%

7%

  Angina, MI

0%

0%

0%

  Depression

32%

37%

17%

  Anxiety

20%

37%

7%

PSS (perceived stress scale, 0–40): Median (1^st quartile, 3^rd quartile, semi-interquartile range)

17.0 (12.0, 24.0, 6.0)

18.0 (12.5, 21.5, 4.5)

7.5 (5.0, 17.0, 4.75)

OAB symptom scores: (mean ± SD)

ICIQ-UI (urinary incontinence, 0–21):

12.0 ± 4.9

6.6 ± 5.7

1.4 ± 2.0

UDI-6 (urogenital distress inventory, 0–24):

12.6 ± 5.6

11.0 ± 5.3

0.9 ± 1.4

IIQ-7 (incontinence impact questionnaire, 0–28):

8.8 ± 8.2

4.9 ± 7.0

0.1 ± 0.4

OAB-q quality of life subscale (13–78):

29.7 ± 16.9

25.1 ± 14.9

2.0 ± 3.0

OAB-q symptom bother subscale (6–36):

19.1 ± 6.6

14.2 ± 7.4

2.2 ± 2.8

ICIQ-OAB (overactive bladder, 0–16):

9.3 ± 2.6

7.3 ± 4.1

2.0 ± 1.5

USS (urgency severity scale, 0–3):

2.1 ± 0.7

1.9 ± 0.8

0.5 ± 0.6

Numeric rating scale of urgency (0–10):

6.1 ± 2.6

5.9 ± 2.8

0.4 ± 0.6

Numeric rating scale of frequency (0–10):

6.4 ± 2.6

6.2 ± 2.3

0.6 ± 0.9